Nadia Hameed, MBChB
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Nadia Hameed
I am an anatomic and clinical pathologist with training in gynecologic pathology. I joined MD Anderson Cancer Center as an Assistant Professor in 2022 after completing my fellowship trainings in both Gynecologic Pathology and Surgical Pathology at the same institution. I have a special interest in ovarian and endometrial tumors. I routinely assess gynecologic pathology cases, including those sent to MD Anderson for referral from outside institutions. I have participated in research projects in pathology, with focus on ovarian neoplasms.
Read More
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Pathology, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, University of Texas Medical Branch, Galveston, TX
Education & Training
Degree-Granting Education
| 2005 | Baghdad University Teaching Hospital, Baghdad, IQ, Medicine and Surgery, Internship |
| 2002 | University of Baghdad, Baghdad, IQ, Medicine and Surgery, MBChB |
Postgraduate Training
| 2021-2022 | Clinical Fellowship, Gynecologic Pathology, University of Texas-M.D. Anderson Cancer Center, Houston, Texas |
| 2020-2021 | Clinical Fellowship, Surgical Pathology, University of Texas-M.D. Anderson Cancer Center, Houston, Texas |
| 2016-2020 | Clinical Residency, Anatomic and Clinical Pathology, University of South Alabama, Mobile, Alabama |
Licenses & Certifications
| 2022 | Texas Medical License |
| 2020 | American Board of Pathology |
| 2016 | Alabama Medical Licensure Commission |
Experience & Service
Extramural Institutional Committee Activities
Member, Institutional Tissue Bank (ITB) Internal Advisory, The University of Texas MD Anderson Cancer Center, 2024 - 2025
Member, Wellness Working Group, The University of Texas MD Anderson Cancer Center, 2023 - Present
Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2023 - 2025
Member, Strategic Operational Priority Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Chair, Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Memeber, Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Editorial Activities
Journal reviewer, International Journal of Gynecologic Cancer, 2025 - Present
Honors & Awards
| 2004 | Distinguished Resident Award, Baghdad Teaching Hospital |
Professional Memberships
Selected Presentations & Talks
International Presentations
- 2025. Yolk Sac Tumor Arising in Association with Ovarian Mucinous Carcinoma: A Very Rare Entity. Poster. International Congress of Korean Society of Pathologist. Seoul, KR.
- 2025. Diagnostic Challenges of Emerging and Common High-Grade Endometrial Carcinoma. Invited. 15th Emirates Pathology, Digital pathology & Cancer Conference. Dubai, AE.
- 2024. Detection of FGFR2:: VCL Fusion in Low Grade Serous Carcinoma, Unique Molecular Finding Previously Undescribed in Ovarian Serous Carcinoma. Poster. International Congress of Korean Society of Pathologist. Seoul, KR.
- 2024. Positive HMB45, Cathepsin K, MITF, and TFE3 in Apoplectic Leiomyomas: A Potential Diagnostic Pitfall. Poster. International Congress of Korean Society of Pathologist. Seoul, KR.
Grant & Contract Support
| Date: | 2022 - Present |
| Title: | The University of Texas MD Anderson Cancer Center Spore in Ovarian Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5P50CA217685-05 |
Selected Publications
Peer-Reviewed Articles
- Kim, M, Asare, A, Dockery, JL, Hameed, N, Sims, TT. Complete response to trastuzumab-deruxtecan (Enhertu, T-DXd) in HER2-positive stage IVB uterine carcinosarcoma. Gynecologic Oncology Reports 60, 2025. e-Pub 2025. PMID: 40687920.
- Shehabeldin A, Rohra P, Sellen LD, Zhao J, Alqaidy D, Aramin H, Hameed N, Perez YE, Lai Z, Tong YT, Milton DR, Edgerton ME, Fuller G, Hansel D, Prieto VG, Ballester LY, Aung PP. Utility of Whole Slide Imaging for Intraoperative Consultation: Experience of a Large Academic Center. Arch Pathol Lab Med 148(6):715-721, 2024. e-Pub 2024. PMID: 37756559.
- Ing BI, Huepenbecker SP, Hameed N, Lu KH. Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report. Gynecol Oncol Rep 49:101287, 2023. e-Pub 2023. PMID: 37840846.
- Rothrock AT, Hameed N, Cho WC, Nagarajan P, Ivan D, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes. J Cutan Pathol 50(3):223-229, 2023. e-Pub 2023. PMID: 36377266.
- Nitecki R, Hameed N, Bhosale P, Shafer A. Growing teratoma syndrome. Int J Gynecol Cancer 33(2):299-303, 2023. e-Pub 2023. PMID: 36746506.
- Anderson S, Hameed N. Tumor Budding and Poorly Differentiated Clusters are Unfavorable Prognostic Factors in Pancreatic Ductal Adenocarcinoma, as Validated by the ITBCC Scoring System. Mod Path, 2022. e-Pub 2022.
- Knowles K, Hameed N. Rare and Unusual Tumors of the Head and Neck; Case Reports and Review of the Literature. American Journal of Otolaryngology and Head and Neck Surgery 2(8), 2019. e-Pub 2019.
- Haque M, Hameed N, Perry CT, Carter E, Mneimneh WS. Malignant Peritoneal Mesothelioma in the setting of a Ventriculo-Peritoneal Shunt: A novel clinical presentation. Clin Med Insights Oncol 12:1179554918779583, 2018. e-Pub 2018. PMID: 29899672.
- Hameed N. Primary vaginal melanoma. International Journal of Gynecological Cancer.
Abstracts
- Hameed N. Retroperitoneal High Grade Anaplastic Leiomyosarcoma with Heterologous Elements: A Previously unreported Presentation. ASCP 2018 150(1):S22-S23.
- Hameed N, Ramalingam P, Euscher E, Malpica A, Marques-Piubelli M. Histologic Features of Ovarian Background Tissue in Primary Mucinous Ovarian Tumors Versus that of Metastasis. USCAP 2022 35(2):753.
- Hameed N, Cho W, Yang R. Detection of FGFR2:: VCL Fusion in Low Grade Serous Carcinoma, Unique Molecular Finding Previously Undescribed in Ovarian Serous Carcinoma. 76th Annual Fall Meeting of the Korean Society of Pathologists.
- Hameed N. Positive HMB45, Cathepsin-K, MITF, and TFE3 in Apoplectic Leiomyomas. International Congress of Korean Society of Pathologist.
- Han J, Ding Y, Hameed N, Weissferdt A, Sun H. TRPS1 and GATA3 Expression in SMARCA4 Deficient Malignant Neoplasms. USCAP 114th Annual Meeting Volume 105(3):736.
- Hameed N, Ramalingam P, Liu J, Malpica A, Euscher ED. Pilomatrix-Like High Grade Endometrioid Carcinoma. USCAP 114th Annual Meeting 105(3):988.
- Haque M, Hameed N. Disseminated Histoplasmosis Presenting as Bilateral Adrenal Masses in an Immunocompetent Adult: Report of Unusual Case Presentation. ASCP 2018 150(1):S78.
- Haque M, Hameed N. Composite Peripheral T-cell Lymphoma and B-cell lymphoma with Immunophenotype of Hairy Cell Leukemia: Report of Unusual Case. ASCP 2018 150(1):s99.
- Haque M, Hameed N. Primary Vaginal T- cell Lymphoma in A Patient with A History of Chronic Lymphocytic Leukemia: A Case Report. ASCP 2018 142(9).
- Haque M, Hameed N. Mixe Phenotype Acute Leukemia Associated with t(8:12): Report of a Rare Case. ASCP 2018 142(9).
- Hameed N. A rare Case of Primary Leiomyosarcoma Arising in the Right Atrium. ASCP 2018 142(9).
- Han J, Hameed N, Lawson B. Interobserver Reproducibility of Folate Receptor Alpha (FOLR1) Scoring in High-Grade Serous Carcinoma. USCAP 2026.
- Hameed N. Reporting Lymph Node Metastasis Size and Extracapsular Extension for Ovarian, Fallopian Tube and Peritoneal Carcinoma Is Not Clinically Relevant. USCAP 2022.
- Hameed N. A Unique Combination of Chromosome 4q Deletion and Chromosome 12q Duplication. ASCP 2017 141:E80.
- Chatmethakul T, Hameed N. Cutaneous Polyarteritis Nodosa associated with Streptococcus Pyogenes Infection. Journal of Investigative Medicine 66(2):481.
- Hameed N, Haque M. A Unique Presentation of Fibrosarcomatous Dermatofibrosarcoma Protuberans of Breast. ASCP 2018 149:S105.
- Haque M, Hameed N. Ovarian Sertoli-Leydig Cell Tumor Presenting with Non-specific Symptoms i an Elderly patient with Family History of Gastrointestinal Stromal Tumor. ASCP 2018 149:S107-108.
- Wang G, Liu Y, Ramalingam P, Malpica A, Euscher E, Lawson B, Hameed N, Sood A, Rafei H, Basar R, Rezvani K, Jazaeri A, Liu J. TROP2 Expression is A Favorable Prognostic Marker in Patients with Advanced High Grade Ovarian Carcinoma. USCAP 12TH Annual Meeting 103(3):S998-S99.
Web Publications
- Hameed N. Clear Cell Carcinoma of the Cervix.
Patient Reviews
CV information above last modified March 26, 2026